Significantly higher levels of IL-6 have been found in serum samples of patients with ESCC, breast cancer, and gastric cancer.53, 54, 55 In ESCC, higher levels of serum IL-6 were closely correlated with chemoresistance and poor survival.56 This evidence concerns the gene IL6 and esophageal squamous cell carcinoma.